NABIL DIB, MD, PhD
SPECIAL ADVISOR TO THE BOARD
Dr Dib serves as a Special Advisor to the Stemedica Board of Directors.
Dr Dib is Director, Clinical Cardiovascular Cell Therapy, Associate Professor of Medicine, University of California, San Diego, Director, Cardiovascular Research and New Devices, Catholic Healthcare West (Chandler Regional and Mercy Gilbert Medical Center) and Director, Cardiovascular and Stem Cell Consultants, P.C.
Dr Dib's research interests include Stem Cell Therapy for Myocardial Regeneration, Methods of Translational Stem Cell Research and Methods of Stem Cell Delivery. Current research studies include a Phase I, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Dose-Escalation Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (ProvacelTM) Following Acute Myocardial Infarction and an Evaluation of the Safety and Feasibility of Myoblast Transplantation Using the Biosense Mapping and Injection System in Patients With Ischemic Cardiomyopathy.
His published work includes contributions to books on cell therapy; Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications. September 2005 and Myocardial Regeneration Via Myoblast Transplantation. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine 2006
Board of Directors...
- Roger J. Howe
PhD, Executive Chairman
- Maynard A. Howe
PhD, Chief Executive Officer and Vice Chairman
- Nikolai I. Tankovich
MD, PhD, FASLMS, President, Chief Regulatory and Medical Officer
- William Maloney, III
MD, Stanford University & Medical Center
- Anthony Marlon
MD, Board Member Nevada Development Authority / University of Nevada Las Vegas Foundation
- Richard Mejia
Chairman of Stemedica Audit Committee
- Neal Matheson
Chief Technology Officer (CTO) for the Johnson & Johnson Family of Consumer Companies
- Dirk P. O'Hara
MBA, JD, Owner, Norman Senior Care, LLC
- Gary M. Petrucci
RBC Wealth Management
- B.G. Rhee
President of Green Cross Holdings